Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Tigulixostat [inn]
2. Wz0pyq6vlu
3. Lc350189
4. Lc-350189
5. 1287766-55-5
6. 1-(3-cyano-1-propan-2-ylindol-5-yl)pyrazole-4-carboxylic Acid
7. 1h-pyrazole-4-carboxylic Acid, 1-(3-cyano-1-(1-methylethyl)-1h-indol-5-yl)-
8. Unii-wz0pyq6vlu
9. Schembl1647151
10. Chembl3652780
11. Bdbm121531
12. Cs-0213580
13. Us8729273, 1
Molecular Weight | 294.31 g/mol |
---|---|
Molecular Formula | C16H14N4O2 |
XLogP3 | 1.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 294.11167570 g/mol |
Monoisotopic Mass | 294.11167570 g/mol |
Topological Polar Surface Area | 83.8 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 486 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
74
PharmaCompass offers a list of Tigulixostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tigulixostat manufacturer or Tigulixostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tigulixostat manufacturer or Tigulixostat supplier.
PharmaCompass also assists you with knowing the Tigulixostat API Price utilized in the formulation of products. Tigulixostat API Price is not always fixed or binding as the Tigulixostat Price is obtained through a variety of data sources. The Tigulixostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tigulixostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tigulixostat, including repackagers and relabelers. The FDA regulates Tigulixostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tigulixostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tigulixostat supplier is an individual or a company that provides Tigulixostat active pharmaceutical ingredient (API) or Tigulixostat finished formulations upon request. The Tigulixostat suppliers may include Tigulixostat API manufacturers, exporters, distributors and traders.
Tigulixostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tigulixostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tigulixostat GMP manufacturer or Tigulixostat GMP API supplier for your needs.
A Tigulixostat CoA (Certificate of Analysis) is a formal document that attests to Tigulixostat's compliance with Tigulixostat specifications and serves as a tool for batch-level quality control.
Tigulixostat CoA mostly includes findings from lab analyses of a specific batch. For each Tigulixostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tigulixostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Tigulixostat EP), Tigulixostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tigulixostat USP).